Jacob Eriksson is a Therapeutic Area Lead at AstraZeneca, focusing on innovations in the treatment of COPD and Vaccine & Immune Therapy. They previously served as a Medical Doctor and Partner at Narva Åderbråckscenter from 2017 to 2023, and held various medical roles, including MD positions at Oslo University Hospital and Akademiska sjukhuset in 2011 and 2013 respectively. Jacob earned their MD in Medicine from Warszawski Uniwersytet Medyczny in 2011 and completed an Executive MBA at the Stockholm School of Economics in 2022.
This person is not in the org chart
This person is not in any teams
This person is not in any offices